Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001069530-19-000030
Filing Date
2019-05-15
Accepted
2019-05-15 17:50:26
Documents
1
Period of Report
2019-05-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT certent-form4.html 4  
1 PRIMARY DOCUMENT certent-form4.xml 4 3559
  Complete submission text file 0001069530-19-000030.txt   5060
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Issuer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12117 BEE CAVES RD BUILDING THREE, SUITE 100 AUSTIN TX 78738
Business Address
Schoen Eric (Reporting) CIK: 0001532303 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29959 | Film No.: 19829927